On Monday, Johnson & Johnson stated that it had halted (for time being) its COVID-19 vaccine candidate clinical trials. This happened after an unexplained illness occurred in a study participant, delaying one of the biggest profile efforts to curb the global pandemic.The illness developed in the participant is being reviewed and studied by an independent data and safety monitoring board along with the clinical and safety physicians of the company, according to the statement.J&J, on Tuesday morning, stated that such halts are normal in trials of this scale, which can consist of tens of thousands of people.
Read more on toopanda.com